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In this issue of Cell, Schindler et al. (2006) show that the Nef protein from nonpathogenic 
strains of simian immunodeficiency virus (SIV) induces the downregulation of host T cell 
receptor/CD3, whereas Nef from human immunodeficiency virus (HIV-1) does not. This loss 
of function in the Nef of HIV-1 may partly explain the pathogenicity of this virus.Despite their relatively small size, the 
nef  genes  of  HIV-1,  HIV-2,  and  SIV 
pack a big punch. Nef is a highly com-
plex  and multifunctional  protein  that 
intersects multiple host cellular path-
ways  essential  for  cell  survival  and 
function.  Despite  extensive  in  vitro 
characterization,  the  role of Nef dur-
ing  in vivo  infection  remains unclear. 
In  this  issue  of Cell,  Schindler  et  al. 
(2006)  present  intriguing  evidence 
suggesting that, during evolution, the 
Nef protein of HIV-1  lost  its ability to 





The  Nef  protein  of  HIV  was  origi-
nally  viewed  as  a  negative  regulator 
of  the  long  terminal  repeat  transcrip-
tional promoter of HIV. As nef  is one 
of  the  HIV-1  genes  not  required  for 
viral production,  it was named  for  its 
presumed negative role (negative fac-
tor).  This  notion  was  dismissed  with 
the finding  that Nef  from  the SIVmac 









Nef  in  both  HIV  and  SIV  pathogen-
esis, and since then, multiple possible 




In  general,  Nefs  from  all  primate 
lentiviruses  (HIV-1,  HIV-2,  and  SIV) 
share multiple activities in vitro. These 
include downregulation of CD4, MHC 
class  I  proteins,  and  CD28  in  host 
cells;  enhanced  infectivity  of  the 
viral  particle;  and  activation  of  cel-
lular  kinases  (Arora  et  al.,  2002).  In 
their new work, Schindler et al. (2006) 
focus  their  attention  on  the  one  in 
vitro  activity  that  is  absent  from  all 
HIV-1 Nefs  tested, namely  the ability 
to  induce  host-cell  TCR-CD3  down-
regulation.  It  is well  established  that 
HIV-1 Nef does not induce TCR-CD3 
downregulation,  whereas  HIV-2  and 
most SIV Nefs do. The Schindler et al. vier Inc.(2006) study now makes an important 
distinction  regarding  Nefs  from  dif-
ferent  species.  Specifically,  the  Nef 
protein  of  SIVcpz,  the  primate  lenti-
virus  that  is  most  closely  related  to 
HIV-1, also does not induce host cells 
to  downregulate  TCR-CD3,  whereas 
Nefs  from  SIVsmm,  the  closest  pri-
mate virus to HIV-2 retain this ability.
Although  sooty  mangabeys  are 
the  natural  host  of  SIVsmm,  this 
strain  of  virus  does  not  cause  dis-
ease  in  a  majority  of  these  animals 
(Rey-Cuille  et  al.,  1998),  but  it  does 
in  rhesus macaques  (Schindler et al., 
2006).  However,  a  small  percentage 
of infected mangabeys do experience 
a decline in the number of their CD4+ 
T cells  that  correlates with  increased 
activation of the immune system. Nefs 
from  the  viruses  present  in  mang-
abeys  that  experienced  CD4+  T  cell 














There  are  two  remarkable  conse-
quences  of  Nef-induced  TCR-CD3 
downregulation (Schindler et al., 2006). 
First,  such  downregulation  blocks  T 
cell activation in vitro by phytohemag-
glutinin  (PHA)  or  antibodies  against 
CD3/CD28.  Second,  this  downregu-
lation results in a marked decrease in 
activation-induced T cell death.  Inter-
estingly,  there  was  no  difference  in 
the  in vitro susceptibility of T cells  to 
FAS-mediated  apoptosis  regardless 
of  which  Nef  protein  was  expressed 
in peripheral blood mononuclear cells. 












TCR-CD3  downregulation,  yet  infec-
tion of chimpanzees with SIVcpz does 
not  result  in  disease  despite  active 
viral  replication.  Another  example  is 
provided  by  humans  infected  with 
HIV-2. Schindler et al. (2006) show that 
HIV-2  is  a  powerful  inducer  of  TCR-
CD3  downregulation  (2-fold  higher 
than  SIVsmm).  Yet  humans  infected 
with HIV-2 develop AIDS, although at 
a slower rate (Marlink et al., 1994).  In 
addition,  rhesus  macaques  infected 
with SIVsmm containing Nefs that are 
fully  capable  of  inducing  TCR-CD3 
downregulation develop AIDS-like dis-
ease.  Another  interesting  pathogen-
esis model is provided by infection of 
pigtailed macaques with  the  SIVagm 

































zee,  which  is  the  source  of  all  three 
human zoonoses); SIVcpz from Pan t. 
schweinfurthii  (the  eastern  chimpan-
zee, with  no  known  transmissions  to 






management  of  viral  infection  awaits 
further investigation.
Phylogenetic analysis of the 30 Nefs 






ent  in  viruses  from  separate  clades. 
This may reflect a recombination event 
between  vpu-positive  and  vpu-nega-
tive viruses that generated a virus con-
taining a vpu gene and a Nef capable 
of  downregulating  TCR-CD3.  Sub-
sequently,  the  nef  newly  associated 
with vpu presumably  lost  its capacity 





SIVrcm  strain  (which  lacks  vpu  and 
downregulates  TCR-CD3)  is  closely 
related  to SIVcpz  (the nonpathogenic 
precursor  to  HIV-1)  with  respect  to 
the  nef, gag,  and pol  genes,  but  the 
env  gene  of  SIVcpz  is  not  derived 
from SIVrcm.  The  fact  that  SIVcpz  is 
nonpathogenic  in  chimpanzees  and 
lacks TCR-CD3 downregulation  abili-
ties  indicates  the  possibility  that  the 
pathogenesis  of  HIV-1  actually might 
not be  related  to  the  fact  that  its Nef 
cannot induce TCR-CD3 downregula-
tion in host T cells.
The  next  step may  be  to  engineer 
a  highly  infectious  HIV-1  strain  con-
taining  a  Nef  that  downregulates 
TCR-CD3. By maintaining viral persis-
tence  in the context of an  intact host 
immune  system,  this  nonpathogenic 
virus  could  potentially  outcompete 
pathogenic viruses. If such a result  is 





Arora,  V.K.,  Fredericksen,  B.L.,  and  Garcia, 
J.V. (2002). Microbes Infect. 4, 189–199.
Deacon,  N.J.,  Tsykin,  A.,  Solomon,  A., 
Smith,  K.,  Ludford-Menting,  M.,  Hooker, 
D.J.,  McPhee,  D.A.,  Greenway,  A.L.,  Ellett, 
A.,  Chatfield,  C.,  et  al.  (1995).  Science 270, 
988–991.
Goldstein,  S.,  Ourmanov,  I.,  Brown,  C.R., 










Muller,  M.C.,  and  Barre-Sinoussi,  F.  (2003). 
Front. Biosci. 8, d1170–d1185.
Rey-Cuille,  M.A.,  Berthier,  J.L.,  Bomsel-
Demontoy,  M.C.,  Chaduc,  Y.,  Montagnier, 
L., Hovanessian, A.G., and Chakrabarti, L.A. 
(1998). J. Virol. 72, 3872–3886.
Schindler, M., Munch,  J.,  Kutsch, O.,  Li, H., 
Santiago,  M.L.,  Bibollet-Ruche,  F.,  Müller-
Trutwin,  M.C.,  Novembre,  F.J.,  Peeters,  M., 
Courgnaud, V., et al. (2006). Cell, this issue.
Simmons, A., Aluvihare, V., and McMichael, A. 
(2001). Immunity 14, 763–777.une 16, 2006 ©2006 Elsevier Inc.  1035
